Jing Ling

495 total citations
48 papers, 287 citations indexed

About

Jing Ling is a scholar working on Hematology, Immunology and Molecular Biology. According to data from OpenAlex, Jing Ling has authored 48 papers receiving a total of 287 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Hematology, 23 papers in Immunology and 15 papers in Molecular Biology. Recurrent topics in Jing Ling's work include Hematopoietic Stem Cell Transplantation (11 papers), Platelet Disorders and Treatments (11 papers) and Acute Lymphoblastic Leukemia research (10 papers). Jing Ling is often cited by papers focused on Hematopoietic Stem Cell Transplantation (11 papers), Platelet Disorders and Treatments (11 papers) and Acute Lymphoblastic Leukemia research (10 papers). Jing Ling collaborates with scholars based in China, United States and Japan. Jing Ling's co-authors include Feiyun Yang, Jianmei Tian, Xiaofang Wu, Jianqin Li, Zhaoyue Wang, Jun Lu, Zhaoyue Wang, Wenshe Ray Liu, Jun Pan and Xiaohua Wu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Frontiers in Immunology.

In The Last Decade

Jing Ling

43 papers receiving 285 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jing Ling China 10 115 104 79 61 37 48 287
Sen Zhang China 10 140 1.2× 121 1.2× 70 0.9× 40 0.7× 62 1.7× 33 364
Eui-Jong Kwon South Korea 3 115 1.0× 112 1.1× 43 0.5× 36 0.6× 73 2.0× 7 365
Chengxin Luo China 10 119 1.0× 89 0.9× 61 0.8× 35 0.6× 98 2.6× 23 363
H.S. Rosário Portugal 7 107 0.9× 152 1.5× 67 0.8× 32 0.5× 42 1.1× 8 377
Fanjun Cheng China 10 172 1.5× 43 0.4× 69 0.9× 66 1.1× 98 2.6× 27 338
Xingkui Xue China 10 176 1.5× 76 0.7× 69 0.9× 20 0.3× 89 2.4× 19 335
Ebru Aydin Sweden 12 139 1.2× 191 1.8× 34 0.4× 47 0.8× 90 2.4× 22 388
Irina Mantovani Italy 8 291 2.5× 42 0.4× 74 0.9× 38 0.6× 98 2.6× 10 381
Natasha S. Anstee Australia 11 193 1.7× 90 0.9× 151 1.9× 38 0.6× 77 2.1× 21 381

Countries citing papers authored by Jing Ling

Since Specialization
Citations

This map shows the geographic impact of Jing Ling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jing Ling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jing Ling more than expected).

Fields of papers citing papers by Jing Ling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jing Ling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jing Ling. The network helps show where Jing Ling may publish in the future.

Co-authorship network of co-authors of Jing Ling

This figure shows the co-authorship network connecting the top 25 collaborators of Jing Ling. A scholar is included among the top collaborators of Jing Ling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jing Ling. Jing Ling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dou, Huan, Junjun Huang, Lu Lu, et al.. (2025). Loganin epigenetically rescues mitochondrial complex III dysfunction via DNMT1-UQCRC1 demethylation to halt cardiac remodeling after myocardial infarction. Phytomedicine. 145. 157001–157001. 1 indexed citations
2.
Tang, Xiaoxuan, Sheng-Chun Dang, Jie Qiu, et al.. (2025). Calcium-dependent adhesion protein CDH18, a potential biomarker for prognosis in uterine corpus endometrial carcinoma. Frontiers in Molecular Biosciences. 12. 1530253–1530253.
4.
Hu, Yixin, Lijun Gao, Zhiheng Li, et al.. (2024). Anagrelide and idarubicin combination induces GSDME-mediated pyroptosis as a potential therapy for high-PDE3A acute myeloid leukemia. Leukemia. 39(1). 98–111. 4 indexed citations
6.
Zheng, Yu, Haihui Jiang, Daosheng Huang, et al.. (2023). Glioma-derived ANXA1 suppresses the immune response to TLR3 ligands by promoting an anti-inflammatory tumor microenvironment. Cellular and Molecular Immunology. 21(1). 47–59. 21 indexed citations
8.
Yao, Yanhua, Bohan Li, Jie Li, et al.. (2023). The frequencies of lymphocyte subsets on “day 30″ correlate with the clinical outcome of pediatric hematopoietic stem cell transplantation. Immunology Letters. 254. 21–29. 2 indexed citations
10.
Xiao, Peifang, Zhiheng Li, Li Gao, et al.. (2022). Decitabine combined with minimally myelosuppressive therapy for induction of remission in pediatric high-risk acute myeloid leukemia with chromosome 5q deletion: a report of three cases. International Journal of Hematology. 116(1). 146–151. 2 indexed citations
11.
12.
Li, Bohan, Lijun Meng, Yuanyuan Tian, et al.. (2021). A Low Level of Plasmacytoid Dendritic Cells at Engraftment Is a Valuable Prognostic Indicator in Children Receiving Allogeneic Hematopoietic Stem Cell Transplantation. Transplantation and Cellular Therapy. 27(7). 611.e1–611.e12. 2 indexed citations
13.
Yin, Jie, Jun Lu, Jian Su, et al.. (2020). Tryptophan 387 and 390 residues in ADAMTS13 are crucial to the ability of vascular tube formation and cell migration of endothelial cells. Clinical and Experimental Pharmacology and Physiology. 47(8). 1402–1409. 2 indexed citations
14.
Li, Jianqin, Jianmei Tian, Jun Lu, et al.. (2020). LncRNA GAS5 inhibits Th17 differentiation and alleviates immune thrombocytopenia via promoting the ubiquitination of STAT3. International Immunopharmacology. 80. 106127–106127. 46 indexed citations
15.
Wang, Liwen, Panpan Zhang, Jieqiong Li, et al.. (2019). High-throughput sequencing of CD4+ T cell repertoire reveals disease-specific signatures in IgG4-related disease. Arthritis Research & Therapy. 21(1). 295–295. 19 indexed citations
16.
Liu, Ling, Jun Pan, Huan Wang, et al.. (2018). von Willebrand factor rescued by miR-24 inhibition facilitates the proliferation and migration of osteosarcoma cells in vitro. Bioscience Reports. 38(6). 12 indexed citations
17.
Ling, Jing, Fei Shen, Liqian Xie, et al.. (2016). [Identification of Monoclonal Antibodies against von Willebrand Factor Cleaving Protease (ADAMTS13) and Their Function].. PubMed. 24(4). 1104–9. 1 indexed citations
18.
Liu, Ling, et al.. (2014). Changes in von Willebrand factor and ADAMTS-13 in patients following arthroplasty. Molecular Medicine Reports. 11(4). 3015–3020. 8 indexed citations
19.
Ling, Jing, et al.. (2013). The WXXW motif in the TSR1 of ADAMTS13 is important for its secretion and proteolytic activity. Thrombosis Research. 131(6). 529–534. 9 indexed citations
20.
Ling, Jing, et al.. (1995). Topological Requirements for Recognition and Cleavage of DNA by Ribosome-Inactivating Proteins. Biological Chemistry Hoppe-Seyler. 376(11). 637–642. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026